Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...

As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing ...

Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a ...

WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to ...

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Sales of Wegovy weight loss jabs soar 27-fold after rival Mounjaro ramps up price in UK - CheqUp said it had experienced a ...

Wegovy (semaglutide) is an injectable medication that’s approved for weight loss. Due to its popularity, fake or counterfeit Wegovy products are on the market.

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.